ARCHIVES

Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study

This article is from The Cancer Letter archive.

Vol. 30 No. 2 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

In Brief: Jay Moskowitz Reassigned; Healy To Run For Ohio Republican Nomination To Senate

September 17, 1993

Shingleton Nominated To President’s Panel

June 10, 1977

Eight States Get Cervical Cancer Screening Planning Contracts

June 21, 1974

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

Minorities Increasingly Involved In Research, Training Programs

December 5, 1986